Why Should You Add Columbia Care to Your Cannabis Portfolio?

This column provides readers with a taste of Cannin’s insights they offer to their members, including investment tips, trends, predictions and more. In this installment, we take a deeper dive into Columbia Care’s financials.

The post Why Should You Add Columbia Care to Your Cannabis Portfolio? appeared first on Cannabis Industry Journal.

3 Cannabis Stocks That Can Gain Over 50% According to Analyst Estimates

We’re pleased to announce our new partnership with Cannin Investment Group, a cannabis investment analysis firm, on this new column. This collaboration will provide readers with a taste of Cannin’s insights and analysis that they offer to their members, including investment tips, trends, predictions, market updates and more.

The post 3 Cannabis Stocks That Can Gain Over 50% According to Analyst Estimates appeared first on Cannabis Industry Journal.

Cannabis M&A in the Post-COVID Era

Prospects for the New Year are expected to continue the explosive year-end trend with a backlog of nearly $2 billion in deals heading into 2021. Growth is expected to be led by multi-state operators who have achieved scale, cleaned up their balance sheets and stockpiled dry powder for roll-up acquisitions.

The post Cannabis M&A in the Post-COVID Era appeared first on Cannabis Industry Journal.